03:32 PM, 17th May 2025
Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve Audited Financial Results for Q and year ended 31.03.2025 and to approve Final Dividend if any for the FY ended 31.03.2025